1. Applying Full Spectrum Analysis to a Raman Spectroscopic Assessment of Fracture Toughness of Human Cortical Bone. Makowski AJ, Granke M, Ayala OD, Uppuganti S, Mahadevan-Jansen A, Nyman JS (2017) Appl Spectrosc 71(10): 2385-2394
    › Primary publication · 28708001 (PubMed) · PMC5561524 (PubMed Central)
  2. Advances in imaging approaches to fracture risk evaluation. Manhard MK, Nyman JS, Does MD (2017) Transl Res : 1-14
    › Primary publication · 27816505 (PubMed) · PMC5357194 (PubMed Central)
  3. 30-Second bound and pore water concentration mapping of cortical bone using 2D UTE with optimized half-pulses. Manhard MK, Harkins KD, Gochberg DF, Nyman JS, Does MD (2017) Magn Reson Med 77(3): 945-950
    › Primary publication · 28090655 (PubMed) · PMC5526671 (PubMed Central)
  4. Tissue-Level Mechanical Properties of Bone Contributing to Fracture Risk. Nyman JS, Granke M, Singleton RC, Pharr GM (2016) Curr Osteoporos Rep 14(4): 138-50
    › Primary publication · 27263108 (PubMed) · PMC4927361 (PubMed Central)
  5. Technical note: Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation. Diez-Perez A, Bouxsein ML, Eriksen EF, Khosla S, Nyman JS, Papapoulos S, Tang SY (2016) Bone Rep : 181-185
    › Primary publication · 27975078 (PubMed) · PMC5152622 (PubMed Central)
  6. SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice. Thrailkill KM, Clay Bunn R, Nyman JS, Rettiganti MR, Cockrell GE, Wahl EC, Uppuganti S, Lumpkin CK, Fowlkes JL (2016) Bone : 101-7
    › Citation · 26211996 (PubMed) · PMC4679447 (PubMed Central)
  7. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease. Newman CL, Creecy A, Granke M, Nyman JS, Tian N, Hammond MA, Wallace JM, Brown DM, Chen N, Moe SM, Allen MR (2016) Kidney Int 89(1): 95-104
    › Citation · 26489025 (PubMed) · PMC4840093 (PubMed Central)
  8. Prevalent role of porosity and osteonal area over mineralization heterogeneity in the fracture toughness of human cortical bone. Granke M, Makowski AJ, Uppuganti S, Nyman JS (2016) J Biomech 49(13): 2748-2755
    › Primary publication · 27344202 (PubMed) · PMC5056137 (PubMed Central)
  9. MRI-derived bound and pore water concentrations as predictors of fracture resistance. Manhard MK, Uppuganti S, Granke M, Gochberg DF, Nyman JS, Does MD (2016) Bone : 1-10
    › Primary publication · 26993059 (PubMed) · PMC4862893 (PubMed Central)
  10. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease. Nyman JS, Merkel AR, Uppuganti S, Nayak B, Rowland B, Makowski AJ, Oyajobi BO, Sterling JA (2016) Bone : 81-91
    › Primary publication · 27423464 (PubMed) · PMC4996753 (PubMed Central)